SCHEMBL25560288

SCHEMBL25560288

CC1(C)OB(c2ccc(C#N)cc2C(=O)OCc2ccccc2)OC1(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 4/20 0.40
CYP3A4 P08684 2/20 0.40
ALOX15 P16050 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 2/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
CASP3 P42574 1/20 0.37
RAB9A P51151 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
MAPT P10636 1/20 0.37
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257906 0.85 TDP1 (0.48) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL4812393 0.84 DHODH (0.46) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL31459270 0.81 CYP11B1 (0.35) ALDH1A1POLB
SCHEMBL6352002 0.78 ALDH1A1 (0.50) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL25560285 0.75 ALDH1A1 (0.50) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL551104 0.74 MRGPRX4 (0.52) ALDH1A1TDP1L3MBTL1KMT2ASLC6A2
SCHEMBL1232020 0.74 CYP3A4 (0.35) ALDH1A1CYP3A4ALOX15MAPT
SCHEMBL2592375 0.73 LMNA (0.46) ALDH1A1TDP1L3MBTL1KMT2ASLC6A2
SCHEMBL24515648 0.73 KMT2A (0.45) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL17981613 0.73 L3MBTL1 (0.41) ALDH1A1TDP1CYP3A4L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159508-A1 INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159508-A1 INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE RIPK1, RIPK2, RIPK4 ALDH1A1 4554/4885TDP1 956/4885CYP3A4 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.